DrugCentral: online drug compendium
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
DrugCentral (http://drugcentral.org) is an open-access online drug compendium. DrugCentral integrates structure, bioactivity, regulatory, pharmacologic actions and indications for active pharmaceutical ingredients approved by FDA and other regulatory agencies. Monitoring of regulatory agencies for new drugs approvals ensures the resource is up-to-date. DrugCentral integrates content for active ingredients with pharmaceutical formulations, indexing drugs and drug label annotations, complementing similar resources available online. Its complementarity with other online resources is facilitated by cross referencing to external resources. At the molecular level, DrugCentral bridges drug-target interactions with pharmacological action and indications. The integration with FDA drug labels enables text mining applications for drug adverse events and clinical trial information. Chemical structure overlap between DrugCentral and five online drug resources, and the overlap between DrugCentral FDA-approved drugs and their presence in four different chemical collections, are discussed. DrugCentral can be accessed via the web application or downloaded in relational database format.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There are 217 drugs annotated in DrugCentral10 as acting through 125 (T) ion channels for the MoA9.”
From Unexplored therapeutic opportunities in the human genome (2018) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Chemical structures were manually assigned to 140 of the latest veterinary drugs, and molecular descriptors and structure depictions were computed per DrugCentral workflow (1).”
From DrugCentral 2023 extends human clinical data and integrates veterinary drugs (2023) · cites this paper as [1]
Experimental — accuracy not yet measuredIn the citing paper
“DrugCentral has been a public digital database aggregating drug information since 2016 (1).”
From DrugCentral 2023 extends human clinical data and integrates veterinary drugs (2023) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
KEGG for integration and interpretation of large-scale molecular data sets
Kanehisa, M., Goto, S., Sato, Y., Furumichi, M., & Tanabe, M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr988 · Cited by 4,848 · cited 2×
“The following resources matched our above inclusion criteria: the ChEMBL database (1), the Guide to Pharmacology (2) and KEGG Drug (3).”
BackgroundMethodThe unified medical language system (UMLS): integrating biomedical terminology
Bodenreider, O. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh061 · Cited by 4,356
A comprehensive map of molecular drug targets
Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T. I., et al. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.230 · Cited by 2,427 · cited 1×
“) to which the API or its active metabolite binds directly, to exert the therapeutic drug action (22).”
BackgroundSelf-citationDrugBank 4.0: shedding new light on drug metabolism
Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, A. C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1068 · Cited by 1,993 · cited 10×
“The overlap matrix was computed for DrugCentral, in comparison with the following drugfocused resources: the NIH Center for Chemical Genomics (NCGC) pharmaceutical collection (11), DrugBank (12), the IDAAPM database (13), the phase 4 drugs subset from the ChEMBL 21 release (1) and the e-Drug3D database (14).”
MethodInfluentialThe ChEMBL bioactivity database: an update
Bento, A. P., Gaulton, A., Hersey, A., Bellis, L. J., Chambers, J., Davies, M., Krüger, F. A., Light, Y., Mak, L., McGlinchey, S., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1031 · Cited by 1,492 · cited 5×
“Mechanism of action annotations in DrugCentral are aggregated from several expert curated resources: ChEMBL database (1), Guide to Pharmacology (2), KEGG Drug (3), as well as manual curations extracted from drug labels and literature.”
BackgroundMethodInfluentialThe SIDER database of drugs and side effects
Kuhn, M., Letunic, I., Jensen, L. J., & Bork, P. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1075 · Cited by 1,451 · cited 3×
“Drug adverse events from FDA AERS database (https://open.fda.gov/) and SIDER (21) will be used to enhance the drug safety profile of existing drug reports.”
BackgroundSouthan, C., Sharman, J. L., Benson, H. E., Faccenda, E., Pawson, A. J., Alexander, S. P. H., Buneman, O. P., Davenport, A. P., McGrath, J. C., Peters, J. A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1037 · Cited by 1,035 · cited 3×
“Quantitative bioactivity data are aggregated from multiple sources including: ChEMBLDb (1) (58.73% of the records); DrugMatrix (23) (15.95%); WOMBAT-PK (24) (13.9%); Guide to Pharmacology (2) (5.29%); PDSP (25) (3.41%); scientific literature (2.35%); and drug labels (0.36%), respectively.”
BackgroundMethodInfluentialCalculating log Poct from structures
Leo, A. J. (1993) · Chemical Reviews · doi:10.1021/cr00020a001 · Cited by 695
Dalby, A., Nourse, J. G., Hounshell, W. D., Gushurst, A. K. I., Grier, D. L., Leland, B. A., & Laufer, J. (1992) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00007a012 · Cited by 642 · cited 1×
“A multistep manual curation and validation process was employed to collect, record and store correct chemical information for API molecular structures in the MDL (‘Molecular Design Limited’) MOL format (8).”
Method
Cited by
Items 201–300 of 336
Mińkiewicz, P., Turło, M., Iwaniak, A., & Darewicz, M. (2019) · Molecules · doi:10.3390/molecules24040789 · Cited by 6
Bridging Stepwise Lab-Informed Pretraining and Knowledge-Guided Learning for Diagnostic Reasoning
Hu, P., Lu, C. H., Wang, F., & Ning, Y. (2026) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2026.3670251 · Cited by 8
“2) DrugCentral [33]: The verified database that provides drug-disease relations, including indications, contraindications, and off-label uses.”
Time-resolved evaluation of compound repositioning predictions on a text-mined knowledge network
Mayers, M., Li, T. S., Queralt-Rosiñach, N., & Su, A. I. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3297-0 · Cited by 6
GraMDTA: Multimodal Graph Neural Networks for Predicting Drug-Target Associations
Yella, J., Ghandikota, S. K., & Jegga, A. G. (2022) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm55620.2022.9995245 · Cited by 6
“More specifically, we collected associations for all the heterogeneous entities from datasets such as DrugBank [22], RepoDB [23], DisGeNET (curated) [24], DrugCentral [25], STRING [26] and Pharos[20].”
MethodHong, Y., Sourander, C., Hackl, B., Patton, J., John, J., Paatero, I., & Coffey, E. T. (2024) · Scientific Reports · doi:10.1038/s41598-024-61337-3 · Cited by 8
The Six Ds of Exponentials and drug discovery: A path toward reversing Eroom’s law
Tropsha, A., Martin, H., & Cherkasov, A. R. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104341 · Cited by 8
Zhang, R., Chen, Z., Li, S., Lv, H., Li, J., Yang, N., & Dai, S. (2025) · Molecules · doi:10.3390/molecules30020260 · Cited by 5
“Information regarding the relationship between drugs, targets, and the indications for which they are used was integrated from the DrugCentral [47], DrugBank, TTD [48], and Pharos databases.”
lncRNAlyzr: Enrichment Analysis for lncRNA Sets
Evangelista, J. E., Ali-Nasser, T., Malek, L. E., Xie, Z., Marino, G. B., Bester, A. C., & Ma’ayan, A. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.168938 · Cited by 5
Prediction of adverse drug reactions due to genetic predisposition using deep neural networks
Dafniet, B., & Taboureau, O. (2024) · Molecular Informatics · doi:10.1002/minf.202400021 · Cited by 5
Artificial Intelligence in Alzheimer’s Drug Discovery
Cheng, F., & Cummings, J. L. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108975759.007 · Cited by 6
The periphery and the core properties explain the omnigenic model in the human interactomePreprint
Wang, B., Glass, K., Röhl, A., Santolini, M., Croteau‐Chonka, D. C., Weiss, S. T., Raby, B. A., & Sharma, A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/749358 · Cited by 5
A Comprehensive Integrated Drug Similarity Resource for In-Silico Drug Repositioning and BeyondPreprint
Azad, A., Dinarvand, M., Nematollahi, A., Swift, J., Lutze-Mann, L. H., & Vafaee, F. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12376505 · Cited by 5
Akmal, M. F., & Wong, M. W. (2025) · Molecules · doi:10.3390/molecules30142992 · Cited by 4
Web-based Tools for Drug Repurposing: Successful Examples of Collaborative Research
Vanhaelen, Q. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200128111925 · Cited by 4
InContext: curation of medical context for drug indications
Moodley, K., Rieswijk, L., Oprea, T. I., & Dumontier, M. (2021) · Journal of Biomedical Semantics · doi:10.1186/s13326-021-00234-4 · Cited by 4
Self-citationA Survey on Covid-19 Knowledge Graphs and Their Data Sources
Khorashadizadeh, H., Tiwari, S. M., & Groppe, S. (2023) · Lecture notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering · doi:10.1007/978-3-031-35078-8_13 · Cited by 4
Genomic-driven nutritional interventions for radiotherapy-resistant rectal cancer patient
Southern, J., Gonzalez, G., Borgas, P., Poynter, L., Laponogov, I., Zhong, Y., Mirnezami, R., Veselkov, D. A., Bronstein, M. M., & Veselkov, K. (2023) · Scientific Reports · doi:10.1038/s41598-023-41833-8 · Cited by 4
John, L., Nagamani, S., Mahanta, H. J., Vaikundamani, S., Kumar, N., Kumar, A., Jamir, E., Priyadarsinee, L., & Sastry, G. N. (2023) · Molecular Diversity · doi:10.1007/s11030-023-10752-1 · Cited by 4
Prasad, R., Kadam, A., Padippurackal, V. V., Balasubramanian, A. P., Chandrakumaran, N. K., Rangari, K. S., Khangar, P. D., Ajith, H., Natarajan, K., Chandramohanadas, R., et al. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2327537 · Cited by 4
“The study used three small molecule libraries: Pandemic Response Box, DrugCentral and FDA approved molecules from the DrugBank database (Samby et al., 2022; Ursu et al., 2016; Wishart et al., 2006).”
Integrative Data Analytic Framework to Enhance Cancer Precision Medicine
Gaudelet, T., Malod‐Dognin, N., & Pržulj, N. (2021) · Network and Systems Medicine · doi:10.1089/nsm.2020.0015 · Cited by 5
Drug repurposing prediction for COVID-19 using probabilistic networks and crowdsourced curationPreprint
Skelton, J., Alsobhe, A., Anastasi, E., Atallah, C., Je, B., Brown, B., Didon, D., Gater, P., James, K., Lennon, D. D., et al. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2005.11088 · Cited by 4
“Data source Date obtained Nodes contributed Edges contributed UniProt [48] 2020-02-11 Proteins Gene -[encodes]- Protein DrugBank [49] 2020-02-11 Drugs Drug -[has target]- Protein Monarch Disease Ontology (MONDO) [50] 2020-02-11 Disorders Disorder -[is subset of]- Disorder Drug Central [51] 2018-08-26 Drug -[has target…”
BackgroundInfluentialDrug Repurposing using consilience of Knowledge Graph Completion methodsPreprint
Tu, R., Sinha, M., Gonzalez-Cavazos, A. C., Hu, E. Y., Dhuliawala, S., McCallum, A., & Su, A. I. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.12.540594 · Cited by 7
“MIND is rooted in MechRepoNet, a knowledge graph reflecting important drug mechanism relationships identified from a curated dataset of biomedical drug mechanisms [14].”
BackgroundGenerating Biomedical Knowledge Graphs from Knowledge Bases, Registries, and Multiomic DataPreprint
Qin, G., Narsinh, K., Wei, Q., Roach, J. C., Joshi, A., Goetz, S. L., Moxon, S. A. T., Brush, M., Xu, C., Yao, Y., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.14.623648 · Cited by 4
GeneRAIN: multifaceted representation of genes via deep learning of gene expression networks
Su, Z., Fang, M., Smolnikov, A., Dinger, M. E., Oates, E. C., & Vafaee, F. (2025) · Genome biology · doi:10.1186/s13059-025-03749-6 · Cited by 3
“We sourced gene attribute databases from the Enrichr database [64–66], as detailed in Additional file 2: Table S3 [26, 47, 67–84].”
Distefano, A., Pappalardo, M., Turco, R., Grasso, G., & Guccione, S. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118621 · Cited by 3
Rajkumar, P., Tang, R., Sapre, H., Zemlin, J., Deleray, V., Seo, J. I., Mohan, S., Xing, S., Gouda, H., Abiead, Y. E., et al. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c05301 · Cited by 3
Sil, P., Tiwari, R., Garisetti, V., Baskaran, S. P., Dhanaseelan, F. H., Srivastava, S., & Samal, A. (2026) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2026.109194 · Cited by 4
Are newer pharmaceuticals more recalcitrant to removal in wastewater treatment?
Straub, J. O., Roux, J. L., & Tedoldi, D. (2022) · Sustainable Chemistry and Pharmacy · doi:10.1016/j.scp.2022.100834 · Cited by 5
Prediction of Drug Side Effects Based on Drug-Related Information
Seo, S., Lee, T., & Yoon, Y. (2019) · The Journal of Korean Institute of Information Technology · doi:10.14801/jkiit.2019.17.12.21 · Cited by 3
Liang, S., Li, H., Liu, D., Lv, W., Wang, S., Liu, J., Greenbaum, J., Shen, H., Xiao, H., & Deng, H. (2022) · Processes · doi:10.3390/pr10020326 · Cited by 3
Polypharmacology in Drug Design and Discovery—Basis for Rational Design of Multitarget Drugs
Wang, Z., & Yang, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-04998-9_12 · Cited by 3
CADD for Cancer Therapy: Current and Future Perspective
Ejiofor, I. I., Ekeomodi, C. C., IlecChukwu, A. U., & Ochiamu, M. C. (2023) · Biological and medical physics, biomedical engineering · doi:10.1007/978-981-19-9786-0_9 · Cited by 5
Ringer, J. A., Lambert, C. G., Bradfute, S. B., Bologa, C., & Yang, J. J. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c02297 · Cited by 3
Self-citationThe ontology reference model for visual selectivity analysis in drug-target interactions
Cheng, Q., Lopez, F. A., Duran, C., Camarillo, C., Oprea, T. I., & Schürer, S. C. (2017) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2017.8217982 · Cited by 3
Self-citationGatarić, B., & Parojčić, J. (2019) · The AAPS Journal · doi:10.1208/s12248-019-0394-y · Cited by 3
“Molecular descriptor values (molecular weight (MW), sum of hydrogen bond donor and hydrogen bond acceptor counts (denoted as HB), and polar surface area (PSA)) were obtained from the PubChem database (20), while calculated LogP values (clogP) were obtained from DrugCentral database (21) (for further consideration, ple…”
MethodSheinerman, F. B. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839163401-00101 · Cited by 4
Kumar, A., Sharanya, C. S., Jayanandan, A., & Sadasivan, C. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12090408 · Cited by 3
TARRAGON: Therapeutic Target Applicability Ranking and Retrieval-Augmented Generation Over NetworksPreprint
Beasley, J.-M. T., Schatz, K., Ding, E., DeLuca, M., Zaid, N. A., Tucker, N., Chirkova, R. Y., Crona, D. J., Tropsha, A., & Muratov, E. N. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.19.649662 · Cited by 3
“We extracted Target-Disease pairs from the DrugMechDB 25 and DrugCentral 26,27 using the ROBOKOP KG by constructing a Cypher query: MATCH (g:`biolink:GeneOrGeneProduct`)-[r0:`biolink:target_for`]- >(d:`biolink:DiseaseOrPhenotypicFeature`) RETURN * Mining and Selection of Target-Disease Association…”
Wang, L., Zhang, B., Wu, H., Shi, Y., Chen, X. '., Ma, Y., & Gao, J. (2025) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbbio.2025.3557709 · Cited by 2
“Specifically, we down-load SMILES information on drugs from DrugBank [22], bingdingDB [26], Drugcentral [27], ChEMBL [28] and Pub-chem [29] databases.”
Shareef, U., Zargaham, M. K., Ibrahim, A., Altaf, A., & Bhatti, R. (2025) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2025.109076 · Cited by 2
VHGAE: Drug-Target Interaction Prediction Model Based on Heterogeneous Graph Variational Autoencoder
Zhang, C., Sun, J., Xing, L., Zhang, L., Cai, H., & Che, K. (2025) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-025-00758-8 · Cited by 2
“DrugCentral [32] is a comprehensive drug information database that includes drug chemical structures, DTIs, drug classifications, drug indications, adverse drug reactions, etc. PubChem [33] is a compound database that contains a large amount of compound structure information, physicochemical…”
Zafar, I., Shafiq, S., Jamal, A., Mohany, M., Shafiq, M., Kamal, M. A., & Khan, N. U. (2025) · Medical Oncology · doi:10.1007/s12032-025-02896-x · Cited by 2
Du, X., Sun, X., Zeng, M., Tan, W., & Li, M. (2025) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbbio.2025.3619038 · Cited by 2
“We focused on the top five predicted potential drugs for AD and BC, verifying these drug-disease associations using reliable sources such as CTD DrugCentral [44] and PubMed.”
DeLuca, M., Matentzoglu, N., Sharp, E., Li, J., Hempstead, C., Lim, M., Kaniewski, P., Carter, E. K., Koirala, K., Ding, E., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1312 · Cited by 2
“Multiple existing databases (e.g. DrugBank [ 26 ], Drug Central [ 27 ], Physician’s Desk Reference [ 28 ]) contain elements of this information.”
Self-citationA case-based explainable graph neural network framework for mechanistic drug repositioning
Gonzalez-Cavazos, A. C., Tu, R., Sinha, M., & Su, A. I. (2026) · Bioinformatics · doi:10.1093/bioinformatics/btag008 · Cited by 4
“To evaluate node contributions within these paths, DBR-X uses a degree-based weighting strategy that accounts for both hub-like and specialized biological entities.”
CellAwareGNN: Single-Cell Enhanced Knowledge Graph Foundation Model for Drug Indication Prediction
Zhang, X., Jeong, E., Yan, C., Feng, Y., Lyu, L., Guo, X., & Chen, Y. (2026) · ACM SIGKDD Conference on Knowledge Discovery and Data Mining (KDD) · doi:10.1145/3770855.3819012 · Cited by 2
“Crucially for drug repurposing, it includes dense, typed therapeutic relationships, such as drug indications, contraindications, and off-label uses, sourced from DrugBank[27] andDrugCentral[48].”
A knowledge-driven framework for predicting single-cell responses for unprofiled drugs
Feng, J., Zhao, Z., Zhang, X., Liu, M., Chen, J., Quan, X., Fu, B., Zhang, J., Wang, Y., Zhang, Y., et al. (2026) · Nature Machine Intelligence · doi:10.1038/s42256-026-01286-w · Cited by 6
A Gene Family-led Meta-Analysis of Drug-Target Interactions
Cheng, Q., Mehta, S., & Schürer, S. C. (2018) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2018.8621087 · Cited by 2
“First, we used the draggable genome described in the IDG project [51, 59-62, 64] as the reference to examine the number of selected targets in a drag target data set.”
MethodYse, D. L., & Torres, D. (2023) · Communications in computer and information science · doi:10.1007/978-3-031-40942-4_8 · Cited by 2
In silico approach for fighting human immunodeficiency virus: a drug repurposing strategy
Crisan, L., & Istrate, D. (2024) · Chemical Papers · doi:10.1007/s11696-024-03789-5 · Cited by 2
“For computational drug repurposing strategy, the entire DrugCentral database (Ursu et al. 2017), consisting of 4099 drugs, was downloaded in simplified molecular input line entry system (SMILES) format.”
Korn, D., Hou, P.-Y., Schatz, K., Beasley, J.-M. T., Tropsha, A., & Chirkova, R. Y. (2024) · ACM Transactions on Computing for Healthcare · doi:10.1145/3707650 · Cited by 3
Protein biomarker druggability profiling
Mani, S., Cannon, D. C., Ohls, R. K., Oprea, T. I., Mathias, S. L., Ballard, K., Ursu, O., & Bologa, C. (2017) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2017.01.014 · Cited by 2
“Moreover, DrugCentral contains additional ~900 drug entries not present in KEGG [36].”
Self-citationLearning reference-enriched approach towards large scale active ontology alignment and integration
Cheng, Q., Ursu, O., Oprea, T. I., & Schürer, S. C. (2017) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2017.8217908 · Cited by 2
“The SNOMED CT is a core clinical healthcare terminology maintained by International Health Terminology Standards Development Organization (IHTSDO®) [16].”
MethodSelf-citationA Computational Platform and Guide for Acceleration of Novel Medicines and Personalized Medicine
Melas, I. N., Sakellaropoulos, T., Hur, J., Messinis, D. E., Guo, E. Y., Alexopoulos, L. G., & Bai, J. P. F. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9089-4_10 · Cited by 2
Lichtenberg, F. R. (2023) · Health Policy and Technology · doi:10.1016/j.hlpt.2023.100726 · Cited by 2
Priyadarsinee, L., Jamir, E., Nagamani, S., Mahanta, H. J., Kumar, N., John, L., Sarma, H., Kumar, A., Gaur, A. S., Sahoo, R., et al. (2024) · Gigabyte · doi:10.46471/gigabyte.114 · Cited by 2
A Comprehensive Integrated Drug Similarity Resource for In-Silico Drug Repositioning and BeyondPreprint
Azad, A., Dinarvand, M., Nematollahi, A., Swift, J., Lutze-Mann, L. H., & Vafaee, F. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12376505.v1 · Cited by 2
REDIAL-2020: A Suite of Machine Learning Models to Estimate Anti-SARS-CoV-2 ActivitiesPreprint
Govinda, K. C., Bocci, G., Verma, S., Hassan, M., Holmes, J., Yang, J. J., Sirimulla, S., & Oprea, T. I. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12915779.v2 · Cited by 2
Self-citationShareef, U., Altaf, A., Zargaham, M. K., Bhatti, R., Ibrahim, A., & Zahid, M. (2023) · Research Square · doi:10.21203/rs.3.rs-3341477/v1 · Cited by 2
Knowledge Graph and Machine Learning Help the Research of Drugs Aimed at Neurological DiseasesPreprint
Menestrina, L., & Recanatini, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.29.626076 · Cited by 2
Makafe, G. G., Cole, L., Roberts, A., Muncil, S. E., Patwardhan, A., Bernacki, D. T., Chojnacki, M., Weinrick, B. C., & Sheinerman, F. B. (2023) · Tuberculosis · doi:10.1016/j.tube.2023.102317 · Cited by 1
Santos, L. A. B. D. O., & Batista, M. V. D. A. (2024) · Microbiology and Immunology · doi:10.1111/1348-0421.13178 · Cited by 1
CPDP: Contrastive Protein–Drug Pre-Training for Novel Drug Discovery
Zhang, S., Wang, X., Li, F., & Peng, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083761 · Cited by 1
“3) [19] and DrugCentral databases [42] by fusing drug indications.”
Drug-target interaction prediction based on metapaths and simplified neighbor aggregation
Yu, D., Yang, X., Shang, Y., Yuan, S., Liu, Y., & Liu, Y. (2025) · Methods · doi:10.1016/j.ymeth.2025.04.012 · Cited by 1
Abdeljaber, L., Alatrush, N., Alsarra, S., Billah, M., Alshammari, A. S., & Khan, L. R. (2025) · IEEE International Conference on Healthcare Informatics (ICHI) · doi:10.1109/ichi64645.2025.00033 · Cited by 1
“For this study, datasets were curated from three public sources: ClinicalTrials.gov [26], DrugCentral [27], and PubMed [25].”
Artificial Intelligence in Drug Discovery and Drug Target Interactions
Iqbal, A. B., Gull, I., Shah, S. Z. A., Assad, A., & Macha, M. A. (2025) · Springer eBooks · doi:10.1007/978-981-96-8176-1_15 · Cited by 1
Conformational Heterogeneity Underlying Divergent Signaling in Class A G Protein-Coupled Receptors
Georgiou, K., & Kolocouris, A. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00102 · Cited by 1
Lone, V., Khona, P., Umekar, M. J., & Kabra, U. D. (2025) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2025.2584054 · Cited by 1
“Virtual screening was performed using two distinct chemical databases: the Enamine database (https://enamine.net) [33] and the DrugCentral database (http://drugcentral. org) [34].”
Imran, M., Aqib, M., Malik, M. A., & Jutt, S. (2026) · Scientific Reports · doi:10.1038/s41598-026-36036-w · Cited by 1
Chirilă, C.-B., & Crisan, L. (2026) · Scientific Reports · doi:10.1038/s41598-026-48926-0 · Cited by 1
“ML techniques were applied to screen all available drugs from the DrugCentral database 61 , identifying those with the highest potential for antiviral repurposing.”
Grandy, C., Donnan, J. R., Peddle, J., Romme, K., Kim, S., & Gamble, J. (2018) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocy074 · Cited by 1
Identification of metabolites identical and similar to drugs as candidates for metabolic engineering
Sinatti, V. V. C., Gonçalves, C. A. X., & Romão‐Dumaresq, A. S. (2019) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2019.06.303 · Cited by 1
Hudson, I., Leemaqz, S., Shafi, S., & Abell, A. D. (2017) · MODSIM · doi:10.36334/modsim.2017.c6.hudson · Cited by 1
Screening and biophysics in small molecule discovery
Wilson, C. G. M., & Arkin, M. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818349-6.00005-4 · Cited by 2
Machine Learning Applications in Anti-cancer Drug Discovery
Sharma, A., & Rani, R. (2021) · EAI/Springer Innovations in Communication and Computing · doi:10.1007/978-3-030-67051-1_10 · Cited by 2
Schiffer, K., Choi, Y. A., & Weng, C. (2023) · PubMed Central · Cited by 2
A Network Medicine Approach to Drug Repurposing for Chronic PancreatitisPreprint
Golden, M., & Wilson, J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.30.360263 · Cited by 1
“We appended this core graph with gene ontologies [37], drug side effects from SIDER [38] and drug-target information from DrugCentral [39].”
MethodREDIAL-2020: A Suite of Machine Learning Models to Estimate Anti-SARS-CoV-2 ActivitiesPreprint
Govinda, K. C., Bocci, G., Verma, S., Hassan, M., Holmes, J., Yang, J. J., Sirimulla, S., & Oprea, T. I. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12915779.v1 · Cited by 1
Self-citationJamir, E., Sarma, H., Priyadarsinee, L., Kiewhuo, K., Nagamani, S., & Sastry, G. N. (2022) · Research Square · doi:10.21203/rs.3.rs-2083023/v1 · Cited by 1
Beyer, B. A., Sul, A., Miller, J., Neumann, B., Plaisted, W. C., Kondo, T., Franklin, R. J. M., & Lairson, L. L. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.11.548469 · Cited by 1
Worley, J., Noh, H., You, D., Turunen, M. M., Ding, H., Paull, E., Griffin, A. T., Grunn, A., Zhang, M., Guillan, K. C., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.08.562798 · Cited by 1
Combination of gene regulatory networks and sequential machine learning for drug repurposing
Réda, C. (2022) · theses.fr (ABES) · doi:10.70675/be6970c6z29eaz447bzbc6az8dc75a827905 · Cited by 3
Weighted Ensemble Approach for Knowledge Graph completion improves performancePreprint
Sinha, M., Tu, R., Gonzalez-Cavazos, A. C., & Su, A. I. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.16.603664 · Cited by 1
A community effort to discover small molecule SARS-CoV-2 inhibitorsPreprint
Schimunek, J., Seidl, P., Elez, K., Hempel, T., Le, T., Noé, F., Olsson, S., Raich, L., Winter, R., Gökcan, H., et al. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-1d5w8 · Cited by 2
Xian, R. P., Lee, A. J., Lolla, S., Wang, V., Cui, Q., Ro, R., & Abbasi-Asl, R. (2024) · arXiv · doi:10.48550/arxiv.2402.10527
“The drug names dataset ( FDA-drugs ) contains over 2.3k unique entities from known drugs approved by the United States Food and Drug Administration (FDA) and curated by Drug Central 5 (Ursu et al., 2017).”
BackgroundAlonso, S. G. (2018) · Gredos (University of Salamanca) · doi:10.14201/gredos.137341
Time-resolved compound repositioning predictions on a text-mined knowledge networkPreprint
Mayers, M., Li, T. S., Queralt-Rosinach, N., & Su, A. I. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/625459
Integration of new pharmacogenomics functionalities in pandrugs
Santos, J., & José, M. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Turanlı, B. (2018) · Marmara University Open Access System
Expanding the Computational Drug Repositioning Toolbox
Brown, A. S. (2017) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Hudson, I. L., Leemaqz, S., & Abell, A. D. (2019) · MODSIM · doi:10.36334/modsim.2019.a1.hudson
“High throughput docking of small molecule ligands (candidate drugs) into high resolution protein structures is now standard in computational approaches to drug discovery (Ursu et al., 2017).”
BackgroundMethodHudson, I. L., Leemaqz, S., & Abell, A. D. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160233-00251
Goicoechea, S. (2020) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/100890
Triangle-Based Tripartite Graph Clustering
Cheng, Y., Yella, J., & Jegga, A. G. (2020) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm49941.2020.9313324
“For drug-disease associations, we collected associations for 3167 drugs and 1620 diseases from DrugCentral [16] and others.”
MethodYedida, R., Beasley, J.-M. T., Korn, D., Abrar, S. M., Melo-Filho, C. C., Muratov, E. N., Graedon, J., Graedon, T., Chirkova, R. Y., & Tropsha, A. (2022) · medRxiv · doi:10.1101/2022.02.02.22270107
“By using this model to mine transcribed episodes of the popular NPR radio show ‘People’s Pharmacy”, we have identified over one-hundred known drug-disease connections (model validation) as well as over a hundred of connections not annotated in popular drug registries such as DrugCentral [16].”
MethodFaculty Opinions recommendation of DrugCentral 2018: an update.
Southan, C. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734312262.793553418
Chakrabarti, S. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736928144.793570010
Búsqueda de nuevos fármacos antichagásicos inhibidores de la Tripanotión sintetasa
Alice, J. I. (2022) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/137336 · Cited by 1
Santamaría, L. P. (2023) · UPM Digital Archive (Technical University of Madrid) · doi:10.20868/upm.thesis.76526
de Lamballerie, C. N. (2020) · theses.fr (ABES) · doi:10.70675/87808fe9zd17fz49d9z994az991c3f0d730f · Cited by 1
Metadata
- Authors
- Ursu, O., Holmes, J., Knockel, J., Bologa, C. G., Yang, J. J., Mathias, S. L., Nelson, S. J., & Oprea, T. I.
- Affiliations
- University of New Mexico (US)
- Corresponding author
- Oprea, Tudor I.
- ORCID
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-10-26
- Volume
- 45
- Issue
- D1
- Pages
- D932-D939
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC5210665
- OpenAlex
- W2539985226
- Cited by
- 323
- References
- 29
- Citations by year
- 2026: 23 · 2025: 39 · 2024: 34 · 2023: 39 · 2022: 26 · 2021: 31 · 2020: 45 · 2019: 40 · 2018: 27 · 2017: 17 · 2016: 2
- FWCI
- 26.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- UNM’s Digital Repository (University of New Mexico) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- European Bioinformatics Institute
- National Institutes of Health
- U.S. Food and Drug Administration
- National Cancer Institute (U54CA189205, P30CA118100)
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- pharmacopoeia, active pharmaceutical ingredients, FDA-approved drugs, drug labels, drug-target interactions, pharmacological activity, drug indications, drug formulation, text mining, drug adverse events
- MeSH terms
- Drug Compounding, Drug Interactions, Drug Labeling, Pharmaceutical Preparations, Humans, United States, United States Food and Drug Administration, Drug Approval, Search Engine, Databases, Pharmaceutical, Drug-Related Side Effects and Adverse Reactions, Web Browser
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.